Pegfilgrastim biosimilar (Hangzhou Jiuyuan Gene Engineering)
培非格司亭生物类似药（杭州九源基因工程）
Report date: 2022/01/21 13:30:13
Base Information
Drug NamePegfilgrastim biosimilar (Hangzhou Jiuyuan Gene Engineering)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesHangzhou Jiuyuan Gene Biomedical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesHangzhou Jiuyuan Gene Biomedical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksN/A